How to increase the value of your practice before selling

Most advice here is a list of things that are obviously good — clean books, happy clients, growth. True, and useless, because it does not tell you which one is worth doing first when you have twelve months and a practice to run.

This ranks them by how much they move the number against what they cost you.

The one that dwarfs the rest

Get yourself out of the clinical seat.

First, and by a wide margin. But not for the reason it is usually sold to you, and the distinction changes what you should actually do.

What it does not do is raise your earnings. You will read that offloading your caseload increases your valuation because a buyer stops deducting the cost of replacing you. Half true, and the half that is missing matters. That deduction — roughly 55 cents of every dollar you personally collect — exists to make the two situations comparable. Hand $100,000 of clients to a clinician and the $55,000 deduction does disappear, but the practice now pays that clinician $55,000 in real money, which comes straight off net income. The valuation model is built so those two paths land in the same place, because economically they are the same place.

If someone tells you shedding your caseload will lift your earnings, they are counting one side of that trade.

What it does do is raise the multiple, and that is where the money is. Moving from a practice where the owner directs clinically to one with a clinical director who is not the owner is worth 0.4× to 0.5× of additional multiple, depending on size. On $450,000 of SDE that is about $180,000, for a change in who signs off on treatment plans.

If you are a solo practice rather than a group, the step in front of you is larger still: going from owner-as-the-practice to a group with associates is worth 0.4× to 0.7×.

The practical consequence is worth sitting with. Because the earnings effect is a wash, the value comes entirely from a buyer believing the practice runs without you — which they will only believe if it has been true for long enough to leave evidence. Clinical decisions with someone else’s name on them. A director who answers the questions during diligence. Twelve to twenty-four months of that, not a reorganisation announced in the month before you go to market.

It is the slowest item on this list and the only one worth more than everything below it combined.

The cheap ones that are worth more than they look

These cost little beyond attention, and each one closes a discount a buyer would otherwise apply.

Get every clinician on a signed, current agreement. With restrictive covenants where your state permits them. A buyer is purchasing a team, and a team with no agreements is a team that can leave the week after closing. This is paperwork, and it is worth more than most six-figure decisions you will make this year.

Move payer contracts to the group. Held by the entity under a group NPI, they transfer with the practice. Following individual clinicians, the buyer re-credentials everyone after closing — months where the work happens and the payment does not. They will price that gap conservatively, and it is one of the largest single discounts in behavioral health deals.

Clean up the add-backs before anyone asks. Every add-back you cannot evidence is earnings a buyer will not credit, and earnings get multiplied. Forty thousand of poorly documented add-backs is not a $40,000 problem — at 2.6× it is a $104,000 one.

Fix documentation for audit survivability. Not clinical quality. Recoupment exposure transfers to the buyer, and diligence exists to find it.

The ones worth doing that will not pay for themselves

Worth saying plainly, because the advice industry rarely does.

Growth for its own sake. Adding revenue at the same margin raises earnings and therefore raises price — but it does not move the multiple, and it consumes the attention you need for the structural work. A year spent growing 15% and a year spent installing a clinical director are not close.

A new EHR. Rarely visible in a valuation. Do it if the current one is actually costing you money, not because it will impress a buyer.

Rebranding, a new website, better marketing collateral. Buyers at this size are underwriting cash flow and transferability. None of them have ever paid more because the logo was good.

What order to do it in

If you have twelve months:

Months one to three. Clinician agreements signed. Add-backs documented as they occur rather than reconstructed later. Start the group contracting process — it takes longer than anyone expects, which is why it goes early.

Months three to nine. Reduce your caseload deliberately, transferring clients to clinicians who will still be there at closing. Identify who becomes clinical director and start moving decisions to them in a way that leaves a trail.

Months nine to twelve. Three years of financials normalised and reconciling to your tax returns. Diligence material assembled before anyone requests it.

If you have twenty-four, the same order with the caseload transition spread over twice as long — which is the version that actually works, because clients and clinicians both absorb it better.

The uncomfortable part

Most of this makes the practice less dependent on you, which means the year you spend raising its value is the year you become less central to it.

Owners consistently find that harder than the work itself. It is worth knowing in advance that the discomfort is a signal the work is landing, not a sign something has gone wrong.

It is also the reason to do it whether or not you sell. A practice that runs without you is worth more to a buyer and better to own.

---

The valuation calculator names the three factors costing you the most, which is where this list should start for your practice rather than in general. It is free and takes about four minutes.

If you would rather work through the sequence with someone who has been on the seller’s side of it, that is what the coaching is for.